跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,282 条关于
“Shanghai HEP Pharmaceutical”
全部
20,282
临床试验
6,192
药物
2,444
机构
2,297
资讯
9,349
去年
Hepatitis D Pipeline Shows Strong Progress with Multiple FDA Breakthrough Designations and Promising Phase 3 Results
去年
RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development
去年
GSK's Bepirovirsen Receives FDA Fast Track for Chronic Hepatitis B Treatment
去年
Fosun Pharma's Innovative Drug Receives Registration Acceptance in China
去年
NIH's TrialGPT AI Algorithm Streamlines Clinical Trial Matching
去年
HepB-CpG Vaccine Shows Superior Protection Against Hepatitis B in People with HIV
去年
BioDuro-Sundia Expands Shanghai Operations with New Kilogram Laboratory and Compound Management Center
去年
CARBOGEN AMCIS Shanghai Facility Receives First Drug Manufacturing License from China's NMPA
去年
FDA Approves Shanghai Henlius Biotech's Novel ALS Drug HLX99
去年
Novartis Expands Strategic Partnership with Shanghai Pharma to Accelerate Ophthalmic Drug Distribution in China
第 1 页，共 935 页
上一页
下一页
